Market Access Glossary: Pharmaceutical Pricing

Pharmaceutical pricing is a complicated and multidimensional process influenced by various elements. Key factors affecting the price of a pharmaceutical product include of the cost of research, manufacturing, marketing, and distribution. 

The initial price is established during the R&D phase. Developing a new drug may take 10 to 15 years and require investment amounting to billions. These costs cover clinical trials, safety and efficacy testing, as well as regulatory approvals. Therefore, part of the drug’s price is intended to offset the risks linked to failed development efforts. 

Once the drug has been developed, manufacturing costs are added. These include expenses for raw materials, equipment, labor, and quality assurance. It is important to highlight that drug manufacturers also bear ongoing marketing and distribution costs post-launch, that impact the drug’s final price. 

Drug price regulation may be the responsibility of various government bodies depending on the country. Most countries have designated agencies tasked with price control and ensuring drug availability. For example, in the USA, these are the Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS). In European countries, national pharmaceutical agencies take on these responsibilities. These agencies may set maximum drug prices and conduct value and effectiveness assessments. In Russia, drug price regulation is handled by the Federal Antimonopoly Service (FAS). Regional governments and Roszdravnadzor supervise the public control of prices on essential medicines available at pharmacies.

In addition, many countries employ negotiation with manufacturers to secure lower prices, particularly for vital and essential drugs. This creates a balance between manufacturers’ interests in making a profit with the consumers’ need for affordable treatment. 

Aston Health experts conduct price analysis throughout the entire lifecycle of a medicinal product to highlight key nuances and craft marketing strategies grounded in the drug’s properties and market environment. Our approach involves examining several parameters, such as the drug’s indications (disease type, patient demographics, etc.), size of the patient population, incremental therapeutic benefits, competitive landscape, and more. We gather, interpret, and deliver to companies comprehensive data on current pricing, price sensitivity forecasts, and recommendations for adjusting pricing and marketing strategies. 

Pricing in the pharmaceutical sector is shaped by a combination of factors and regulatory oversight. Understanding this process is essential to grasping drug costs and the significance of making pharmaceuticals accessible to the public.